Question 1

What are the potential side effects of IKT-001?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH) clinical trial (NCT07632898). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH) clinical trial (NCT07632898). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the study visits involve and how often will I need to come in?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH) clinical trial (NCT07632898). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH) clinical trial (NCT07632898). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH) clinical trial (NCT07632898). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my health be monitored throughout the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH) clinical trial (NCT07632898). Contact the study team or your healthcare provider for specific answers.

What this study is about